Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Change in Accured Expenses (2013 - 2026)

Updated

Neurogene's Change in Accured Expenses came in at $4.1 million for Q2 2026, up 88.5% from $2.17 million a year earlier.

Analysis

Neurogene (NGNE) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Neurogene reported Change in Accured Expenses of $6.15 million, up 229.2% year-over-year; for FY2025, it was $1.67 million.

  • Change in Accured Expenses carries a five-year compound annual growth rate of -11.2% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was -$2.77 million in FY2024, -$3.57 million in FY2023, $806,000 in FY2022 and -$142,000 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Change in Accured Expenses in data going back to Q1 2013.
  • Year-over-year, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 260.9%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q2 2025 (growth of 949.3%), and the weakest in Q3 2025 (a decline of 86.2%).
  • Business Quant data shows NGNE's Change in Accured Expenses at $359,000 (Q1 2026), $1.33 million (Q4 2025) and $365,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Neurogene 578.46 Mn 578.46 Mn - 4.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.10 Mn
Mar 31, 2026 359,000.00
Dec 31, 2025 1.33 Mn
Sep 30, 2025 365,000.00
Jun 30, 2025 2.17 Mn
Mar 31, 2025 -2.20 Mn
Dec 31, 2024 -743,000.00
Sep 30, 2024 2.64 Mn
Jun 30, 2024 207,000.00
Mar 31, 2024 -4.88 Mn
Dec 31, 2023 -3.66 Mn
Sep 30, 2023 1.38 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 -2.44 Mn
Dec 31, 2022 -1.02 Mn
Sep 30, 2022 1.21 Mn
Jun 30, 2022 1.38 Mn
Mar 31, 2022 -769,000.00
Dec 31, 2021 -474,000.00
Sep 30, 2021 1.49 Mn
API Access

Neurogene Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NGNE&period=max&api_key=YOUR_API_KEY